Update shared on 12 Nov 2025
Supreme Petrochem's analyst price target remains unchanged at ₹717, as analysts maintain their outlook. This is despite slightly reduced revenue growth and profit margin expectations, which are offset by a lower discount rate and a modest increase in forecasted future P/E.
What's in the News
- Board meeting scheduled for October 24, 2025, at 15:30 IST to review the company's unaudited financial results for the second quarter and half year ended September 30, 2025 (Key Developments).
- The agenda also includes reviewing the company’s Statement of Assets and Liabilities and Cash Flow Statement (Key Developments).
- The board will consider an interim dividend on the paid-up equity share capital for the financial year 2025-2026 and determine the record date (Key Developments).
Valuation Changes
- Consensus Analyst Price Target remains unchanged at ₹717.
- The discount rate has decreased slightly from 13.55% to 13.37%.
- The revenue growth projection has fallen marginally from 21.20% to 20.73%.
- The net profit margin estimate has decreased slightly from 7.77% to 7.63%.
- The future P/E has increased modestly from 26.15x to 26.82x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.